Oncology Central

Current status and future trends in cervical cancer screening


Dr Philip Castle talks to Michael Dowdall, Managing Commissioning Editor

Dr Philip Castle is an independent consultant, the Executive Director of Global Cancer Initiative (MD, USA), and the Executive Director of the Global Coalition against Cervical Cancer. Previously, Dr Castle was the Chief Scientific Officer of the American Society for Clinical Pathology (2011–2012). He was a Senior Tenured Investigator (2010–2011) and Tenure Track Investigator (2003–2010) in the Division of Cancer Epidemiology and Genetics at the US National Cancer Institute. He received his PhD in biophysics in 1995 and MPH in epidemiology in 2000 from the Johns Hopkins University (MD, USA). Dr Castle’s professional interests are epidemiology of human papilloma viruses (HPV) and cervical/anogenital cancer, science and translation of cancer prevention strategies, evidence-based medicine, and international health.

To view restricted content, please:

Leave A Comment